Boston Scientific

Open: 52.49 Close: 52.44 Change: -0.05

How to get information about Boston Scientific Company Inc without reading the whole internet.

The game is changing. There is a new strategy to evaluate Boston Scientific fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, system, result, September, implanted, raise, …

Concept Map

Semantic Network

Stock Summary

Boston Scientific develops, manufactures, and markets medical devices for use in various interventional medical specialties. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat.

Today's Summary

CEO Michael F. Mahoney sold 113,355 shares in a transaction that occurred on Tuesday, September 12th. Boston Scientific Corp. had annual revenue of $12.68B with 6.68% growth in 2022.

Today's News

Boston Scientific launches next-gen insertable cardiac monitor. LUX-Dx II+ with dual-stage algorithms to detect and verify potential arrhythmias before alerting clinicians. Boston Scientific Corporation will webcast its conference call discussing financial results and business highlights for the third quarter ending September 30, 2023. The safety of these therapies in patients implanted with the Boston Scientific DBS System has not been established. Patients implanted with Boston Scientific systems without ImageReady™ MRI Technology should not be exposed to Magnetic Resonance Imaging. Cambridge Investment Research Advisors Inc. raised its stake in shares of Boston Scientific Co. (BSX – Get Free Report ) CEO Michael F. Mahoney sold 113,355 shares in a transaction that occurred on Tuesday, September 12th. Boston Scientific last issued its quarterly earnings results on July 27th. Boston Scientific Corp. had annual revenue of $12.68B with 6.68% growth in 2022. Boston Scientific to acquire Relievant Medsystems. Boston Scientific is a medical device company located in Massachusetts, United States, which is part of the Healthcare sector. Boston Scientific stock last closed at $52.80 , down 1.07% from the previous day, and has increased 34.21% in one year. WallStreetZen was designed to help everyday investors do more accurate fundamental analysis. The consensus analyst rating on Boston Scientific is a Strong Buy. Stifel Nicolauss Rick Wise raised their price target on Boston. from $58 to $60. Boston Scientific has announced US Food Administration (FDA) clearance of the AVVIGO+ multi-modality guidance system, a next-generation intravascular ultrasound (IVUS) and fractional flow reserve (FFR) system. Boston Scientific: Encouraging and Empowering Tomorrows STEM Pioneers. Boston Scientific gets FDA approval for intravascular ultrasound.

Stock Profile

"Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts."

Keywords

How much time have you spent trying to decide whether investing in Boston Scientific? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, system, result, September, implanted, raise, and the most common words in the summary are: boston, scientific, job, stock, market, news, best, . One of the sentences in the summary was: had annual revenue of $12.68B with 6.68% growth in 2022.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #boston #scientific #job #stock #market #news #best.